Trademark: NOPALINAZA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for NOPALINAZA
We do not have any records of a proof of use for NOPALINAZA at this moment.
Possible trademark infringements of NOPALINAZA
Basic Information about NOPALINAZA
- Serial Number
- 97276456
- Filing Date
- 21 Feb 2022
- Registration Number
- 7110723
- Registration Date
- 18 Jul 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NOPALINAZA on the blockchain with WikiTrademarks.io.
- First use of NOPALINAZA anywhere
- NOPALINAZA was first used on 30 Sep 2004 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns NOPALINAZA?
1. Ibitta Enterprises, Inc, SOUTH GATE CA
2. Ibitta Enterprises, Inc, SOUTH GATE CA
3. Ibitta Enterprises, Inc, SOUTH GATE CA
Correspondent
- IBITTA ENTERPRISES, INC,
- 4593 FIRESTONE BLVD
- 4593 FIRESTONE BLVD
- SOUTH GATE, CA 90280
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io